Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Holding DE:137?
Track your performance easily
Aldeyra Therapeutics (137) Ownership Overview
19.01% Insiders
11.23% Mutual Funds
34.14% Other Institutional Investors
10.18% ETFs
25.44% Public Companies and
Individual Investors
The ownership structure of Aldeyra Therapeutics (DE:137) stock is a mix of institutional, retail, and individual investors. Approximately 55.55% of the company’s stock is owned by Institutional Investors, 19.01% is owned by Insiders, and 25.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 21, 2024 | Nancy Miller Rich Director | xxxxxxxxxxxxx | $10447 |
| Aug 14, 2024 | xxxxxxxxxxxxx | $75874 | |
| Apr 08, 2024 | Perceptive Advisors Llc >10% Owner | xxxxxxxxxxxxx | $833867 |
| Apr 03, 2024 | Perceptive Advisors Llc >10% Owner | xxxxxxxxxxxxx | $1934505 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $2695000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,275,851 | Insider | 15.58% | 44,551,912 | |
| 9,275,851 | Institution | 15.58% | 44,551,912 | |
| 2,879,606 | Institution | 4.84% | 13,830,748 | |
| 2,456,281 | Institution | 4.12% | 11,797,518 | |
| 2,120,302 | Institution | 3.56% | 10,183,811 | |
| 1,471,298 | Insider | 2.47% | 7,066,644 | |
| 680,004 | Institution | 1.14% | 3,266,059 | |
| 666,826 | Institution | 1.12% | 3,202,765 | |
| 575,624 | Institution | 0.97% | 2,764,722 | |
| 530,393 | Institution | 0.89% | 2,547,478 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,456,281 | Institution | 4.12% | 11,797,518 | |
| 680,004 | Institution | 1.14% | 3,266,059 | |
| 575,624 | Institution | 0.97% | 2,764,722 | |
| 530,393 | Institution | 0.89% | 2,547,478 | |
| 495,144 | Institution | 0.83% | 2,378,177 | |
| 310,125 | Institution | 0.52% | 1,489,530 | |
| 239,261 | Institution | 0.40% | 1,149,171 | |
| 234,668 | Institution | 0.39% | 1,127,110 | |
| 206,748 | Institution | 0.35% | 993,011 | |
| 146,590 | Institution | 0.25% | 704,072 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Aldeyra Therapeutics (DE:137)?
According to the latest TipRanks data, approximately 34.14% of the company's stock is held by institutional investors, 19.01% is held by insiders, and 25.44% is held by retail investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.14% of Aldeyra Therapeutics (DE:137) stock is held by institutional investors.
What percentage of Aldeyra Therapeutics (DE:137) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.44% of Aldeyra Therapeutics (DE:137) stock is held by retail investors.
Who owns the most shares of Aldeyra Therapeutics (DE:137)?
Perceptive Advisors Llc owns the most shares of Aldeyra Therapeutics (DE:137).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.